Scientist, drug developer, leader, and executive with a 20+ year track record of success in leading programs through all stages of drug development and companies from start-up through established pharma • Developed eight new chemical entities leading to 15 new drug products, 11 each with >$1B in annual peak sales • Built exceptional technical, multi-disciplinary, and leadership teams • Key contributor to rapid and sustained company growth from a single asset into a multi-product, market-leading portfolio, which included antiviral, cardiovascular, infectious disease, inflammation, and oncology therapeutic areas • Member of founding management team that raised over $300MM and advanced the company from inception, discovery, and through Phase 2 testing in less than three years • Skilled executive as a key member of the leadership team, advisor to CEO/C-suite on organizational capability, governance, and build-out